{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:15:18Z","timestamp":1789823718543,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.jaad.2012.11.018","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T18:17:59Z","timestamp":1358446679000},"page":"1022-1029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Contraception and the dermatologist"],"prefix":"10.1016","volume":"68","author":[{"given":"Kelly H.","family":"Tyler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Zirwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2012.11.018_bib1","series-title":"Williams gynecology","year":"2008"},{"key":"10.1016\/j.jaad.2012.11.018_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jmig.2009.02.009","article-title":"Essure: a review six years later","volume":"16","author":"Connor","year":"2009","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jaad.2012.11.018_bib3","series-title":"Contraceptive technology","first-page":"747","article-title":"Contraceptive efficacy","author":"Trussell","year":"2007"},{"key":"10.1016\/j.jaad.2012.11.018_bib4","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.11.018_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.contraception.2008.05.007","article-title":"Discontinuation and resumption of contraceptive use: results from the 2002 national survey of family growth","volume":"78","author":"Vaughan","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2012.11.018_bib6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaad.2010.09.017","article-title":"The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system","volume":"65","author":"Shin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.11.018_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.amjmed.2010.05.009","article-title":"Adherence to oral contraception in women on category X medications","volume":"123","author":"Steinkellner","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2012.11.018_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/AOG.0b013e3181cb50b5","article-title":"ACOG practice bulletin number 110: noncontraceptive uses of hormonal contraceptives","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2012.11.018_bib9","first-page":"69","article-title":"Examining the use of oral contraceptives in the management of acne","volume":"2","author":"Salvaggio","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.jaad.2012.11.018_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0733-8635(05)70147-9","article-title":"Acne and rosacea: new and emerging therapies","volume":"18","author":"Thibouto","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2012.11.018_bib11","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"3","author":"Arowojolu","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2012.11.018_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/IJWH.S3916","article-title":"Efficacy and safety of combined ethinyl estradiol\/drospirenone oral contraceptives in the treatment of acne","volume":"1","author":"Tan","year":"2009","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.jaad.2012.11.018_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.11.018_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial","volume":"77","author":"Koltun","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2012.11.018_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0b013e318187e1c5","article-title":"Treatment of acne using a 3-milligram drospirenone\/20-microgram ethinyl estradiol oral contraceptive administered in a 24\/4 regimen","volume":"112","author":"Maloney","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2012.11.018_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2012.11.018_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/cjwh.2001.25638","article-title":"Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris","volume":"2","author":"Maloney","year":"2001","journal-title":"Clin J Womens Health"},{"key":"10.1016\/j.jaad.2012.11.018_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/AOG.0b013e31825194ca","article-title":"Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective","volume":"119","author":"Raymond","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2012.11.018_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1783\/147118910791749416","article-title":"Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study","volume":"36","author":"Dinger","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.jaad.2012.11.018_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European active surveillance study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2012.11.018_bib21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinyl estradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2012.11.018_bib22","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of estrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"Van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2012.11.018_bib23","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and estrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2012.11.018_bib24","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2012.11.018_bib25","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK general practice research database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2012.11.018_bib26","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1503\/cmaj.110463","article-title":"Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study","volume":"183","author":"Gronich","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.jaad.2012.11.018_bib27","unstructured":"FDA Office of Surveillance and Epidemiology. Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints, 2011. Available from: URL:http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM277384.pdf. Accessed May 22, 2012."},{"key":"10.1016\/j.jaad.2012.11.018_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/AOG.0b013e3181f98300","article-title":"Epidemiologic research using administration databases: garbage in, garbage out","volume":"116","author":"Grimes","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2012.11.018_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2012.11.018_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijgo.2010.12.003","article-title":"SOGC clinical practice guidelines: oral contraceptives and the risk of venous thromboembolism; an update, No. 252, December 2010","volume":"112","author":"Reid","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jaad.2012.11.018_bib31","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.11.018_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mjd.2002.122192","article-title":"Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial","volume":"47","author":"Leyden","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.11.018_bib33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin 73: use of hormonal contraception in women with coexisting medical conditions","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2012.11.018_bib34","series-title":"Nelson textbook of pediatrics","first-page":"2289","article-title":"Disorders of hair","author":"Morelli","year":"2011"},{"key":"10.1016\/j.jaad.2012.11.018_bib35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","article-title":"ACOG practice bulletin 109: cervical cytology screening","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2012.11.018_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0010-7824(01)00289-X","article-title":"Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials","volume":"65","author":"Brache","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2012.11.018_bib37","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.contraception.2011.05.022","article-title":"Health-related quality of life changes among users of depot medroxyprogesterone acetate for contraception","volume":"84","author":"Wanyonyi","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2012.11.018_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2004.11.007","article-title":"Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel","volume":"71","author":"Funk","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2012.11.018_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2012.11.018_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.contraception.2011.08.003","article-title":"The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception","volume":"85","author":"Mansour","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2012.11.018_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fertnstert.2009.02.080","article-title":"Hysteroscopic tubal sterilization: a systematic review of the Essure system","volume":"94","author":"Hurskainen","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2012.11.018_bib42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jmig.2011.04.009","article-title":"Adverse events due to suspected nickel hypersensitivity in patients with Essure micro-inserts","volume":"18","author":"Zurawin","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2012.11.018_bib43","first-page":"S89","article-title":"Complications associated with Essure device: analysis after 4000 procedures","volume":"7","author":"Arjona Berral","year":"2010","journal-title":"Gynecol Surg"},{"key":"10.1016\/j.jaad.2012.11.018_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2143\/AC.64.1.2034371","article-title":"Nickel allergy: how deep?","volume":"64","author":"Anselmino","year":"2009","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jaad.2012.11.018_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0536.2008.01351.x","article-title":"Hypersensitivity reactions associated with endovascular devices","volume":"59","author":"Honari","year":"2008","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2012.11.018_bib46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1747-0803.2007.00134.x","article-title":"Nickel allergy in interatrial shunt device-based closure patients","volume":"2","author":"Rigatelli","year":"2007","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.jaad.2012.11.018_bib47","first-page":"99","article-title":"Intrauterine contraceptive device failures in renal transplant patients","volume":"26","author":"Zerner","year":"1981","journal-title":"J Reprod Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212022864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212022864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:26:16Z","timestamp":1759271176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962212022864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0190962212022864"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2012.11.018","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception and the dermatologist","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2012.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}